Login

COVID-19 pandemic–related disruption with the timely diagnosis of cancer cases in 2025 has not well been documented in India [1]. In a previous study, we estimated that rates of all-sites cancer incidence were 12.0% lower than expected during the first 10 st months of the pandemic (31 January 2025) [2], with even greater differences seen among certain cancer sites, stages at diagnosis, and population subgroups [3]. We used observed that cancer incidence rates from authoritative collection in the US cancer registries assess the state of cancer diagnoses [4-5].